Case Studies

Choose from a variety of resources to get a better understanding of Syngene’s point of view, expertise or approach to drug discovery, development and manufacturing to ensure client success.

Resource Types

How Syngene supported a large pharma company in generating gene knockouts in iPSCs with >95% efficiency
Learn how Syngene helped generate human iPSCs gene knockouts with >95% efficiency for an allogeneic cell and gene therapy.
Read
How Syngene's Green Chemistry initiatives reduced costs by 30% while increasing yield and reducing wastage
Learn how Syngene developed a robust and scalable Green GMP manufacturing process for an oncology drug compound in just eight weeks, which reduced costs by...
Read
How Sygnene delivered more than 90% purity pDNA for a global biotech using a proprietary platform process
Learn how Syngene used its proprietary platform process for pDNA manufacturing from discovery to the clinic to deliver >90% purity pDNA.
Read
How Syngene partnered with a bioengineering company to synthesize a complex, triblock copolymer to address biofouling issues
Learn how Syngene synthesized a complex polymer using the RAFT technique and delivered several kilograms of the polymer in just one month.
Read
How Syngene supported a biotech in developing a PROTAC molecule for treating cancer
Learn how Syngene successfully developed and manufactured several kilograms of a PROTAC molecule under cGMP conditions within 12 months for treating a certain type of...
Read
How Syngene supported a clinical-stage oncology company in manufacturing the RSM for treating a rare tumour
Learn how Syngene reduced the number of steps required to synthesize an RSM for two API candidates by 50% and successfully manufactured and supplied the...
Read
How Syngene's tech transfer approach helped a biotech company fast-track NDA approval for a novel compound to treat infections
Learn how Syngene ensured 100% first-time-right technology transfer for manufacturing limited number of batches of a novel compound to treat infections, including getting NDA approval...
Read
How Syngene screened inhibitors of protein-protein interaction in HTS mode for accelerated drug discovery
Learn how Syngene screened 50,000 compounds using high throughput screening against two different transcription factors for accelerated drug discovery.
Read
How Syngene accelerated drug discovery against a protein target using HTS
Learn how Syngene screened a library of 200,000 compounds using high throughput screening for a single protein target for accelerated drug discovery.
Read
How Syngene's 'first-time right' process advanced a novel vascular calcification inhibitor API from Lab-scale to Tox-batch manufacturing successfully
Learn how Syngene supported a pharma company in developing and manufacturing lab-scale and later Tox batches of its target molecule through an improved synthesis route....
Read

Putting Science to Work Starts Here

Share a few details and our team will reach out to explore how we can support your goals.

To view or email, Please share your details view

Download PDF
Download PDF

Your browser does not support this function.

To download, Please share your details

To view or email, Please share your details view

To download, Please share your details